EP3444281
IMPROVED PEPTIDE PHARMACEUTICALS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
20.11.2013EP published:
3.11.2021EP application number:
18183208.0
EPO information:
European Patent Register
Max expiry date:
19.11.2033
Title in English:
IMPROVED PEPTIDE PHARMACEUTICALSLanguage of the patent:
English
Timeline
Today
20.11.2013EP application
3.11.2021EP Publication
Owner
Name:
Eumederis Pharmaceuticals, Inc.Address:
12707 High Bluff Drive, Suite 200, San Diego, CA 92130, US
Inventor
Name:
NESTOR, John, JAddress:
Sugar Land, TX 77479, US
Priority
Number:
201261728667 PDate:
20.11.2012Country:
US
Classification
Categories:
C07K 19/00, C07K 7/06, A61K 38/08, C07K 1/107, A61K 38/00, A61K 38/07, A61K 38/26, A61K 38/29, C09D 101/28, C07K 5/065